Skip to content
Screener

Inspire Medical Systems INSP Total Liabilities & Equity

Total Liabilities & Equity at other companies

ResMed logo
ResMedRMD
$8.97B+9.7%
LivaNova logo
LivaNovaLIVN
$2.64B+5.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$873.02M+4.3%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$98.9M-10.3%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$93.42M+211%
Globus Medical logo
Globus MedicalGMED
$5.49B+10.6%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.7B-26.6%
Enterprise value$1.63B-27.3%
P/E13×-30.7×
P/S1.9×-0.8×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: Inspire Medical Systems’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001609550-26-000023
Line itemMarch 31, 2026December 31, 2025
Stockholders' equity:
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding
Common Stock, $0.001 par value; 200,000,000 shares authorized; 28,802,039 and 28,579,015 issued and outstanding at March 31, 2026 and December 31, 2025, respectively2929
Additional paid-in capital950,449927,159
Accumulated other comprehensive (loss) income(352)464
Accumulated deficit(157,786)(146,492)
Total stockholders' equity792,340781,160
Total liabilities and stockholders' equity$911,376$907,317

Item 1. Financial Statements.

FAQ

What is Inspire Medical Systems's total liabilities & equity?
Inspire Medical Systems (INSP) reported total liabilities & equity of $911.38M in Q1 2026.
How has Inspire Medical Systems's total liabilities & equity changed year-over-year?
Inspire Medical Systems's total liabilities & equity increased by 24.7% year-over-year, from $730.81M to $911.38M.
What is the long-term trend for Inspire Medical Systems's total liabilities & equity?
Over 5 years (2020 to 2025), Inspire Medical Systems's total liabilities & equity has grown at a 26.4% compound annual growth rate (CAGR), from $281.19M to $907.32M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about Inspire Medical Systems's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude